The new algorithm achieves greater predictive performance than existing tools, which may help healthcare professionals identify high-risk individuals earlier and better tailor prevention and treatment...
Read moreBiorce has closed a $52.5 million investment round (approximately €44.3 million) with the aim of accelerating the development of its artificial intelligence software for clinical trials and strength...
Read moreEn el Día Mundial del Cáncer, especialistas del Cancer Center Clínica Universidad de Navarra destacan los grandes avances en el diagnóstico, tratamiento y seguimiento integral de los pacientes onc...
Read moreCada 4 de febrero, con motivo del Día Mundial contra el Cáncer, desde CIC bioGUNE se sumamos a la comunidad internacional para concienciar sobre la importancia de la investigación científica en...
Read moreGENESIS Biomed closes 2025 as its best year ever, with strong growth compared to 2024: 506 projects (+26.5%) and 323 customers (+43.6%).
Read moreA study led by the ITACA Institute shows that AI is helping to improve early diagnosis, advanced monitoring and the prediction of complications in premature newborns or those with serious pathologies....
Read moreMonQAI is a digitalform payment aimed at hospitals, ethics and drug research committees and clinical trial promoters that use generative artificial intelligence (AI) to streamline and optimize the cli...
Read moreThe importance of supply chain management in pharma extends far beyond operational efficiency. It directly determines whether a child in rural Kenya receives the same quality of vaccine as one in Bost...
Read moreÚltimamente parece que todo se puede resolver con inteligencia artificial (IA). Y en parte es cierto; la IA puede ayudar a clasificar, predecir, detectar anomalías o resumir información con una efi...
Read moreLa nueva metodología permite reducir un 12% el margen de error en la predicción del rendimiento de cultivos como el brócoli y optimizar el análisis del uso del agua
Read moreSparingVision, a clinical-stage genomic medicine company transforming the treatment of retinal diseases, today announced that it has successfully completed dosing in its Phase I/II PRODYGY clinical tr...
Read moreResearchers from the SPILab laboratory of the Quercus Software Engineering group at the University of Extremadura have designed an AI tool to detect melanomas from clinical images.
Read more